Drug: |
||||
---|---|---|---|---|
Trial Name: |
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor (EORTC-62024) |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Unknown |
|||
Phase: |
3 |
Start Date 12/01/2004 |
Age of Trial (yrs) 19.9 |
|
Treatment Phase: |
Adjuvant |
|||
Drug Category: |
KIT/PDGFRA inhibitor |
|||
Strategy: |
Block KIT |
|||
Trial Type: |
Specifically GIST and only GIST |
|||
Other Protocol IDs: |
CDR0000410825, EORTC-62024, ISG-62024, FRE-FNCLCC-EORTC-62024, GEIS-EORTC-62024, EUDRACT-2004-001810-16 |
|||
Sponsor: |
EORTC,
ISG,
FNCLCC,
GEIS |
|||
Patient Contact: |
111 sites recruiting. Lookup NCT00103168. If using clinicaltrials.gov use 'Focused Search' and 'NCT or Study ID' field. If using cancer .gov use 'Advanced Search' and enter NCT # in 'Protocol ID' field |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
Randomized |
|||
IV or Oral: |
Oral |
|||
Trial Notes: |
Closed to new patients as of CTOS 11/15/2008. Closure date was 10/20/2008. Clinicaltrials.gov does not reflect closure as of 11/6/2012. |
Trial Links |
Trial Results |
Name |
Address |
City |
State |
Zip |
Country |